cardiology careers collections past issues search home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 1 Effect of rosiglitazone on E-selectin and von Willebrand factor levels. Paired results at baseline and after 12 weeks of treatment are shown in each treatment group. Boxes indicate mean values, and bars represent 95% confidence intervals. *p < 0.05 for the change in the rosiglitazone versus placebo group.





Right arrow Return to article

 
  cardiology careers collections past issues search home